Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model
mSphere · 2025
DOI: 10.1128/msphere.00906-24 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift mSphere, 2025. Verfasst von Zachary Liechty und 6 weiteren Autor:innen. Beteiligte Einrichtung: 711th Human Performance Wing, Air Force Research Laboratory, Wright-Patterson Air Force Base, Dayton, Ohio, USA. Hauptthemen laut MEDLINE: Dysentery, Bacillary, Gastrointestinal Microbiome, Shigella sonnei. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Defense Health Program Joint Program Committee-5 Working Group, Military Infectious Disease Research Program.
Abstract (Originalsprache)
Shigella is a significant cause of diarrhea, predominantly affecting children in low- and middle-income countries, as well as international travelers. Not all individuals exposed to Shigella or other enteropathogens have symptomatic responses, and investigating the differences between symptomatic and asymptomatic individuals can further our understanding of enteropathogen proliferation and symptomatic responses. Here, we profiled the fecal microbiomes of 45 individuals infected with Shigella sonnei strain 53G through 16S rRNA sequencing in a controlled human infection model before and during infection, after antibiotic treatment, and after clinical recovery. This model allowed for a detailed exploration of microbiome temporal dynamics during infection, as well as a comparative analysis between those with shigellosis (defined as severe symptoms caused by Shigella infection, including severe diarrhea, fever, and/or abdominal pain) and those without shigellosis. Alpha diversity decreased to a greater degree in individuals with shigellosis. Perturbations in microbial composition during infection and antibiotic treatment were significantly larger in individuals diagnosed with shigellosis than in those who were not. Participants with shigellosis had persistent changes to their microbiomes after recovery, while those without shigellosis recovered to a composition resembling their pre-infection microbiomes. These persistent changes included taxa associated with gut inflammation, such as a decrease in Faecalibacterium and an increase in Ruminococcus gnavus . Furthermore, the initial microbiomes of participants who did not develop shigellosis had a greater abundance of taxa associated with short-chain fatty acid production than participants who did develop shigellosis, including Bifidobacterium , Roseburia , and Faecalibacterium . These data could help prevent Shigella infection or symptoms. IMPORTANCE Diarrheal disease is a major contributor to the global disease burden and can lead to an increased individual risk of chronic sequelae post-infection, such as irritable bowel syndrome, reactive arthritis, and altered gut permeability. Understanding the differential responses of individuals to enteropathogen exposure can elucidate factors that could lead to treatments or preventative measures to reduce the disease burden. Here, we use a controlled human infection model study to directly identify the effects of Shigella sonnei 53G infection on the microbiome. We identified taxa that were more or less abundant in participants who would develop shigellosis during the study, as well as persistent changes after recovery in the microbiomes of participants who developed severe symptoms. Understanding these changes could elucidate ways to prevent Shigella infection or recover altered microbiomes after recovery. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT02816346 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 711th Human Performance Wing, Air Force Research Laboratory, Wright-Patterson Air Force Base, Dayton, Ohio, USA.
- Health and Performance Technologies Division, Blue Halo, Inc., Dayton, Ohio, USA.
- Translational and Clinical Research Department, Naval Medical Research Command, Silver Spring, Maryland, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
- Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Zachary Liechty, Robert Frenck, Michael Goodson
Förderung
- Defense Health Program Joint Program Committee-5 Working Group
- Military Infectious Disease Research Program
Zitieren
APA
Liechty, Z., Baldwin, A., Isidean, S., Suvarnapunya, A., Frenck, R., Porter, C., & Goodson, M. (2025). Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model. mSphere. https://doi.org/10.1128/msphere.00906-24
Vancouver
Liechty Z, Baldwin A, Isidean S, Suvarnapunya A, Frenck R, Porter C, et al. Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model. mSphere. 2025. doi:10.1128/msphere.00906-24
BibTeX
@article{Liechty2025,
author = {Liechty, Zachary and Baldwin, Arianna and Isidean, Sandra and Suvarnapunya, Akamol and Frenck, Robert and Porter, Chad and Goodson, Michael},
title = {Dynamics of the gut microbiome in subjects challenged with Shigella sonnei 53G in a controlled human infection model},
journal = {mSphere},
year = {2025},
doi = {10.1128/msphere.00906-24}
}
EUVIMED